Help fight rare diseases by becoming a cosponsor of the bipartisan RARE Act (H.R. 4228)!

Please join Rep. Richard Hudson (NC-R-8) and I and become a cosponsor of the
Rare diseases Advancement, Research, and Education (RARE) Act (H.R. 4228) in the 116th Congress. This bipartisan bill will expand the ability of the National Institutes of Health (NIH) and Centers for Diseases Control and Prevention (CDC)
to study rare diseases by improving treatment, research, and diagnostics of rare diseases through new and existing programs. This legislation has been endorsed by 139 patient groups.

Read More

BIPARTISAN RESOLUTION – H. RES. 539 CELEBRATE AND SUPPORT THE AMERICAN LEGION

            Please join me in cosponsoring H. Res. 539, a resolution supporting the goals and ideals of the American Legion. As one of the foremost wartime veterans’ service organizations, the American Legion has advocated on behalf of a countless number
of veterans, servicemembers, families, and communities. Additionally, the Legion remains one of the most prominent organizations committed to mentoring youth, sponsoring community programs, advocating patriotism and honor, and furthering a long-lasting devotion
to men and women who served in uniform.

Read More

Help fight rare diseases by becoming a cosponsor of the bipartisan RARE Act (H.R. 4228)!

Please join Rep. Richard Hudson (NC-R-8) and I and become a cosponsor of the
Rare diseases Advancement, Research, and Education (RARE) Act (H.R. 4228) in the 116th Congress. This bipartisan bill will expand the ability of the National Institutes of Health (NIH) and Centers for Diseases Control and Prevention (CDC)
to study rare diseases by improving treatment, research, and diagnostics of rare diseases through new and existing programs. This legislation has been endorsed by 139 patient groups.

Read More

Help fight rare diseases by becoming a cosponsor of the bipartisan RARE Act (H.R. 4228)!

Please join Rep. Richard Hudson (NC-R-8) and I and become a cosponsor of the
Rare diseases Advancement, Research, and Education (RARE) Act (H.R. 4228) in the 116th Congress. This bipartisan bill will expand the ability of the National Institutes of Health (NIH) and Centers for Diseases Control and Prevention (CDC)
to study rare diseases by improving treatment, research, and diagnostics of rare diseases through new and existing programs. This legislation has been endorsed by 139 patient groups.

Read More

LAST CALL FOR ORIGINALS! Help fight rare diseases by becoming an original cosponsor of the bipartisan RARE Act!

Please join Rep. Richard Hudson (NC-R-8) and I and become an original cosponsor of the
Rare diseases Advancement, Research, and Education (RARE) Act in the 116th Congress. This bipartisan bill will expand the ability of the National Institutes of Health (NIH) and Centers for Diseases Control and Prevention (CDC) to study
rare diseases by improving treatment, research, and diagnostics of rare diseases through new and existing programs. This legislation has been endorsed by 139 patient groups.

Read More

Deadline extended! Help fight rare diseases by becoming an original cosponsor of the bipartisan RARE Act!

Please join Rep. Richard Hudson (NC-R-8) and I and become an original cosponsor of the
Rare diseases Advancement, Research, and Education (RARE) Act in the 116th Congress. This bipartisan bill will expand the ability of the National Institutes of Health (NIH) and Centers for Diseases Control and Prevention (CDC) to study
rare diseases by improving treatment, research, and diagnostics of rare diseases through new and existing programs. This legislation has been endorsed by 139 patient groups.

Read More

Deadline extended! Help fight rare diseases by becoming an original cosponsor of the bipartisan RARE Act!

Please join Rep. Richard Hudson (NC-R-8) and I and become an original cosponsor of the
Rare diseases Advancement, Research, and Education (RARE) Act in the 116th Congress. This bipartisan bill will expand the ability of the National Institutes of Health (NIH) and Centers for Diseases Control and Prevention (CDC) to study
rare diseases by improving treatment, research, and diagnostics of rare diseases through new and existing programs. This legislation has been endorsed by 139 patient groups.

Read More

LAST CALL FOR ORIGINALS! Help fight rare diseases by becoming an original cosponsor of the bipartisan RARE Act!

Please join Rep. Richard Hudson (NC-R-8) and I and become an original cosponsor of the
Rare diseases Advancement, Research, and Education (RARE) Act in the 116th Congress. This bipartisan bill will expand the ability of the National Institutes of Health (NIH) and Centers for Diseases Control and Prevention (CDC) to study
rare diseases by improving treatment, research, and diagnostics of rare diseases through new and existing programs. This legislation has been endorsed by 139 patient groups.

Read More

CELEBRATE AND SUPPORT THE AMERICAN LEGION – BIPARTISAN RESOLUTION – H.R. 539

            Please join me in cosponsoring H. Res. 539, a resolution supporting the goals and ideals of the American Legion. As one of the foremost wartime veterans’ service organizations, the American Legion has advocated on behalf of a countless number
of veterans, servicemembers, families, and communities. Additionally, the Legion remains one of the most prominent organizations committed to mentoring youth, sponsoring community programs, advocating patriotism and honor, and furthering a long-lasting devotion
to men and women who served in uniform.

Read More

Add Your Boss? Help fight rare disease by becoming an original cosponsor of the bipartisan RARE Act!

Please join Rep. Richard Hudson (NC-R-8) and I and become an original cosponsor of the
Rare diseases Advancement, Research, and Education (RARE) Act in the 116th Congress. This bipartisan bill will expand the ability of the National Institutes of Health (NIH) and Centers for Diseases Control and Prevention (CDC) to study
rare diseases by improving treatment, research, and diagnostics of rare diseases through new and existing programs. This legislation has been endorsed by 139 patient groups.

Read More